menu
    • menu

    Company profile for Disc medicine

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic dise...
    Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic diseases. Our core development programs target hepcidin biology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Disc medicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Technology Square, Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.discmedicine.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Disc Completes Enrollment in APOLLO Trial for EPP Protoporphyria
    Disc Completes Enrollment in APOLLO Trial for EPP Protoporphyria

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263439/0/en/Disc-Medicine-Announces-Completion-of-Enrollment-of-Phase-3-APOLLO-Trial-of-Bitopertin-in-Erythropoietic-Protoporphyria.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Disc Lays Off 20% Of Workforce In Wake Of FDA Rejection
    Disc Lays Off 20% Of Workforce In Wake Of FDA Rejection

    03 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com//www.fiercebiotech.com/biotech/disc-lays-20-employees-it-steadies-ship-after-fda-rejection-rare-disease-drug

    FIERCE PHARMA
    03 Mar 2026
    Share Share
    Disc Medicine To Participate In Upcoming Investor Conferences
    Disc Medicine To Participate In Upcoming Investor Conferences

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243611/0/en/Disc-Medicine-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Disc Medicine Taps Ex-FDA Leaders to Revive Rejected Drug
    Disc Medicine Taps Ex-FDA Leaders to Revive Rejected Drug

    17 Feb 2026

    // BIOSPACE

    https://www.biospace.com/fda/discs-regulatory-comeback-plan-for-rejected-drug-relies-on-old-fda-leadership

    BIOSPACE
    17 Feb 2026
    Share Share
    FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad
    FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad

    16 Feb 2026

    // BIOSPACE

    https://www.biospace.com/fda/fda-rejects-discs-rare-blood-disease-drug-amid-reports-of-prasads-skepticism

    BIOSPACE
    16 Feb 2026
    Share Share
    Disc's Rare Disease Drug Hit By FDA Rejection
    Disc's Rare Disease Drug Hit By FDA Rejection

    14 Feb 2026

    // PRESS RELEASE

    https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-receives-complete-response-letter-fda-bitopertin

    PRESS RELEASE
    14 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search